SCHEMBL1858809

SCHEMBL1858809

CCCCCCC(=O)Nc1ccnn1C

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.51
LMNA P02545 1/20 0.51
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
SOAT1 P35610 5/20 0.48
SOAT2 O75908 3/20 0.48
DEGS1 O15121 1/20 0.48
RAB9A P51151 1/20 0.47
HPGD P15428 1/20 0.47
CETP P11597 1/20 0.46
KMT2A Q03164 1/20 0.46
CTSK P43235 1/20 0.46
NPC1 O15118 1/20 0.45
GLA P06280 1/20 0.45
MAPK1 P28482 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30516912 0.94 POLB (0.51) POLBLMNAHSP90AA1HSP90AB1RAB9A
SCHEMBL1863751 0.90 POLB (0.46) POLBLMNAHSP90AA1HSP90AB1SOAT1
SCHEMBL1867068 0.90 POLB (0.46) POLBLMNAHSP90AA1HSP90AB1SOAT1
SCHEMBL4138545 0.89 KMT2A (0.48) POLBLMNAHSP90AA1HSP90AB1SOAT1
SCHEMBL1863466 0.87 POLB (0.48) POLBLMNAHSP90AA1HSP90AB1SOAT1
SCHEMBL5849567 0.84 POLB (0.56) POLBHSP90AA1HSP90AB1KMT2AMAPK1
SCHEMBL4124902 0.82 POLB (0.44) POLBHSP90AA1HSP90AB1HPGDKMT2A
SCHEMBL26789473 0.81 POLB (0.59) POLBHSP90AA1HSP90AB1RAB9AHPGD
SCHEMBL4133128 0.80 PKM (0.56) KMT2A
SCHEMBL13678948 0.79 CTSK (0.42) POLBHSP90AA1HSP90AB1KMT2ACTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110105597-A1 Modulation of pathogenicity QUONOVA, LLC 2011-05-05 US disclosed
US-20110105597-A1 Modulation of pathogenicity QUONOVA, LLC 2011-05-05 US disclosed
US-20110105597-A1 Modulation of pathogenicity QUONOVA, LLC 2011-05-05 US disclosed
US-20100280036-A1 Modulation of Pathogenicity QUONOVA, LLC 2010-11-04 US disclosed
US-20100280036-A1 Modulation of Pathogenicity QUONOVA, LLC 2010-11-04 US disclosed
US-20090076012-A1 Modulation of pathogenicity QUONOVA, LLC 2009-03-19 US disclosed
US-20090076012-A1 Modulation of pathogenicity QUONOVA, LLC 2009-03-19 US disclosed
US-20080214635-A1 Modulation of pathogenicity QUONOVA, LLC 2008-09-04 US disclosed
US-20080214635-A1 Modulation of pathogenicity QUONOVA, LLC 2008-09-04 US disclosed
US-20080194607-A1 Modulation of pathogenicity QUONOVA, LLC 2008-08-14 US disclosed
US-20080188536-A1 Modulation of pathogenicity QUONOVA, LLC 2008-08-07 US disclosed
US-20080188536-A1 Modulation of pathogenicity QUONOVA, LLC 2008-08-07 US disclosed
US-20080188491-A1 Modulation of pathogenicity QUONOVA, LLC 2008-08-07 US disclosed
US-20080182878-A1 Modulation of pathogenicity QUONOVA, LLC 2008-07-31 US disclosed
US-20080182878-A1 Modulation of pathogenicity QUONOVA, LLC 2008-07-31 US disclosed
US-20080182878-A1 Modulation of pathogenicity QUONOVA, LLC 2008-07-31 US disclosed
US-20080176938-A1 Modulation of pathogenicity QUONOVA, LLC 2008-07-24 US disclosed
US-20080176938-A1 Modulation of pathogenicity QUONOVA, LLC 2008-07-24 US disclosed
US-7335779-B2 Modulation of pathogenicity QUONOVA, LLC (US) 2008-02-26 US disclosed
US-7335779-B2 Modulation of pathogenicity QUONOVA, LLC (US) 2008-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076012-A1 Modulation of pathogenicity NR4A1, NR4A2, NR4A3 POLB 3354/4885LMNA 3658/4885HSP90AA1 2484/4885
US-20110105597-A1 Modulation of pathogenicity NR4A1, NR4A2, NR4A3 POLB 3327/4885LMNA 3684/4885HSP90AA1 2488/4885
US-20080214635-A1 Modulation of pathogenicity NR4A1, NR4A2, NR4A3 POLB 3327/4885LMNA 3684/4885HSP90AA1 2488/4885
US-20100280036-A1 Modulation of Pathogenicity NR4A1, NR4A2, NR4A3 POLB 3327/4885LMNA 3684/4885HSP90AA1 2488/4885
US-20080182878-A1 Modulation of pathogenicity NR4A1, NR4A2, MSR1 POLB 3349/4885LMNA 3656/4885HSP90AA1 2491/4885
US-20080188491-A1 Modulation of pathogenicity NR4A1, MSR1, NR4A2 POLB 3265/4885LMNA 3578/4885HSP90AA1 2585/4885
US-20080194607-A1 Modulation of pathogenicity NR4A1, NR4A2, NR4A3 POLB 3327/4885LMNA 3684/4885HSP90AA1 2488/4885
US-20080188536-A1 Modulation of pathogenicity NR4A1, NR4A2, NR4A3 POLB 3327/4885LMNA 3684/4885HSP90AA1 2488/4885
US-20080176938-A1 Modulation of pathogenicity NR4A1, NR4A2, NR4A3 POLB 3431/4885LMNA 3839/4885HSP90AA1 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.